X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.
Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJ, Aubourg P, Poll-The BT.
Orphanet J Rare Dis. 2012 Aug 13;7:51. doi: 10.1186/1750-1172-7-51.
An update on the diagnosis and treatment of adrenoleukodystrophy.
Gujral J, Sethuram S.
Curr Opin Endocrinol Diabetes Obes. 2023 Feb 1;30(1):44-51. doi: 10.1097/MED.0000000000000782. Epub 2022 Nov 14.
X-linked adrenoleukodystrophy.
Aubourg P, Mandel JL.
Ann N Y Acad Sci. 1996 Dec 27;804:461-76. doi: 10.1111/j.1749-6632.1996.tb18637.x.
Peroxisomal leukodystrophy.
Engelen M.
Handb Clin Neurol. 2024;204:139-145. doi: 10.1016/B978-0-323-99209-1.00021-1.
X-linked adrenoleukodystrophy: pathogenesis and treatment.
Engelen M, Kemp S, Poll-The BT.
Curr Neurol Neurosci Rep. 2014 Oct;14(10):486. doi: 10.1007/s11910-014-0486-0.
Progress in X-linked adrenoleukodystrophy.
Moser H, Dubey P, Fatemi A.
Curr Opin Neurol. 2004 Jun;17(3):263-9. doi: 10.1097/00019052-200406000-00005.
Adrenoleukodystrophy.
Cappa M, Bizzarri C, Vollono C, Petroni A, Banni S.
Endocr Dev. 2011;20:149-160. doi: 10.1159/000321236. Epub 2010 Dec 16.
Therapy of X-linked adrenoleukodystrophy.
Moser HW.
NeuroRx. 2006 Apr;3(2):246-53. doi: 10.1016/j.nurx.2006.01.004.
Adrenoleukodystrophy.
Moser HW.
Curr Opin Neurol. 1995 Jun;8(3):221-6. doi: 10.1097/00019052-199506000-00011.
[X-linked adrenoleukodystrophy (ALD)].
Imamura A.
Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):315-21.
